{"id":"NCT02172950","sponsor":"CSL Behring","briefTitle":"An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A","officialTitle":"A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII-SingleChain, CSL627) in Subjects With Severe Hemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-13","primaryCompletion":"2021-01-19","completion":"2021-01-19","firstPosted":"2014-06-24","resultsPosted":"2021-10-27","lastUpdate":"2021-10-27"},"enrollment":246,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia A","Severe Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"rVIII-SingleChain","otherNames":["CSL627"]}],"arms":[{"label":"Previously treated patients (PTPs)","type":"EXPERIMENTAL"},{"label":"Previously untreated patients (PUPs)","type":"EXPERIMENTAL"}],"summary":"This multicenter, open-label, phase 3 extension study will investigate the safety and efficacy of rVIII-SingleChain for prophylaxis and on-demand treatment of bleeding episodes in at least 200 previously treated patients (PTPs) with severe congenital hemophilia A and previous exposure to FVIII products who achieve at least 100 exposure days (EDs) to rVIII-SingleChain in this study, as well as in previously untreated patients (PUPs) with no previous exposure to any FVIII product who achieve at least 50 EDs to rVIII-SingleChain in this study. A substudy (open to both PTPs and PUPs) will investigate the use of rVIII-SingleChain in surgery. A substudy (open to PUPs who develop an inhibitor to rVIII-SingleChain) will investigate the use of rVIII-SingleChain in immune tolerance induction (ITI) therapy.","primaryOutcome":{"measure":"Incidence of Inhibitor Formation to FVIII in Previously Treated Patients (PTPs) With 100 Exposure Days (EDs) to CSL627","timeFrame":"At the closest visit after 100 EDs (up to 5 years).","effectByArm":[{"arm":"CSL627: Previously Treated Patients (PTPs)","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":64,"countries":["United States","Australia","Austria","Canada","Czechia","France","Georgia","Germany","Hungary","Ireland","Italy","Japan","Lebanon","Malaysia","Netherlands","Philippines","Poland","Portugal","Romania","South Africa","Spain","Switzerland","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":222},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Pyrexia","Arthralgia","Headache"]}}